Patents Assigned to Juno Therapeutics GmbH
  • Publication number: 20190136186
    Abstract: Provided herein are methods that relate, in some aspects, to the incubation or culturing, such as to induce stimulation of expansion (proliferation), activation, costimulation and/or survival, of a composition of cells, such as a population of lymphocytes. In some aspects, provided are methods and reagents for the stimulation, e.g., of expansion (proliferation), survival or persistence, activation, costimulation, or other effect, of cell populations that involve binding of agents to a molecule on the surface of the cells, thereby providing one or more signals to the cells. In some cases, the reagents are reagents containing a plurality of binding sites for agents, such as multimerization reagents, and thus the one or more agents are multimerized by reversibly binding to the reagent, e.g., thereby creating a stimulatory reagent (multimerized agent), having stimulatory agents multimerized thereon.
    Type: Application
    Filed: October 20, 2016
    Publication date: May 9, 2019
    Applicant: Juno Therapeutics GmbH
    Inventors: Lothar GERMEROTH, Christian STEMBERGER, Patricia GRÄF, Keenan BASHOUR
  • Publication number: 20190112576
    Abstract: Provided herein are methods for culturing cells, including stimulating or expanding (proliferating), a plurality of cells in a composition of cells such as a population of lymphocytes. In some aspects, provided methods and reagents for the culturing, such as stimulation or expansion (proliferation), of cell populations involve binding of agents to a molecule on the surface of the cells, thereby providing one or more signals to the cells. In some cases, the reagents are multimerization reagents and the one or more agents are multimerized by reversibly binding to the reagent. In some aspects, the multimerized agent can provide for expansion or proliferation or other stimulation of a population of cells, and then such stimulatory agents can be removed by disruption of the reversible bond. Also provided are compositions, apparatus and methods of use thereof.
    Type: Application
    Filed: October 20, 2016
    Publication date: April 18, 2019
    Applicant: Juno Therapeutics GmbH
    Inventors: Lothar GERMEROTH, Christian STEMBERGER, Patricia GRÄF
  • Patent number: 10228312
    Abstract: The present invention relates to the chromatographic isolation of a target cell or another complex biological material, in particular by column chromatography such as affinity chromatography or gel permeation chromatography. The invention employs a receptor binding reagent that binds to a receptor molecule that is located on the surface of a target cell. The invention in general provides novel methods for the traceless isolation of biologic materials such as cells, cell organelles, viruses and the like. The invention also relates to an apparatus for the isolation of cells and other complex biological materials.
    Type: Grant
    Filed: February 25, 2013
    Date of Patent: March 12, 2019
    Assignee: Juno Therapeutics GmbH
    Inventor: Herbert Stadler
  • Publication number: 20170037368
    Abstract: The present invention relates to in vitro-methods of expanding a population of cells such as lymphocytes, comprising contacting a sample comprising a population of cells with a multimerization reagent. The multimerization reagent has reversibly immobilized thereon (bound thereto) a first agent that provides a primary activation signal to the cells and optionally, a second agent that provides a co-stimulatory signal. The invention also provides multimerization reagents, kits, arrangements and an apparatus for expanding cells.
    Type: Application
    Filed: April 16, 2015
    Publication date: February 9, 2017
    Applicant: Juno Therapeutics GmbH
    Inventors: Lothar GERMEROTH, Christian STEMBERGER